# Neuropsychiatric Interpretative Electroencephalograph Assessment Aid
> **Product code: NCG** · Class II — Moderate Risk (510(k) clearance required) · Neurology · 21 CFR 882.1440
## Classification
- **FDA Product Code:** NCG
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 882.1440
- **Review panel:** NE
- **Medical specialty:** Neurology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

Uses a patient's electroencephalograph (EEG) to provide an interpretation of the patient's neuropsychiatric condition.  It is also used only as an assessment aid for a medical condition for which there exists other valid methods of diagnosis."

## Market data
- **Cleared 510(k) submissions:** 3
- **Registered establishments:** 1
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=NCG)
---
*AI Analytics · CC0 1.0*